X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1740) 1740
rats (1298) 1298
sarcoma, yoshida (611) 611
male (432) 432
mice (395) 395
sarcoma, yoshida - metabolism (364) 364
sarcoma, yoshida - drug therapy (361) 361
neoplasm transplantation (323) 323
female (283) 283
sarcoma (215) 215
humans (213) 213
sarcoma, experimental (203) 203
neoplasms (200) 200
sarcoma, yoshida - pathology (186) 186
neoplasms, experimental (163) 163
research (150) 150
rats, inbred strains (139) 139
liver neoplasms (138) 138
oncology (131) 131
in vitro techniques (127) 127
time factors (122) 122
sarcoma, yoshida - enzymology (115) 115
sarcoma, yoshida - immunology (100) 100
ascites (96) 96
antineoplastic agents (92) 92
antineoplastic agents - pharmacology (92) 92
yoshida sarcoma (84) 84
cell line (73) 73
neoplasms, experimental - drug therapy (72) 72
antineoplastic agents - therapeutic use (70) 70
carcinoma, ehrlich tumor (70) 70
liver - metabolism (69) 69
radiation effects (69) 69
tritium (69) 69
kinetics (67) 67
neoplasms, experimental - metabolism (67) 67
carcinoma, hepatocellular (61) 61
liver - enzymology (60) 60
cells, cultured (59) 59
carcinoma, ehrlich tumor - drug therapy (58) 58
neoplasm metastasis (58) 58
rabbits (57) 57
dna, neoplasm - biosynthesis (54) 54
carcinoma, ehrlich tumor - metabolism (52) 52
culture techniques (51) 51
pharmacology (51) 51
transplantation, homologous (51) 51
cell division (48) 48
cell division - drug effects (48) 48
nitrogen mustard compounds - pharmacology (48) 48
pharmacology & pharmacy (48) 48
sarcoma, yoshida - blood (48) 48
mechlorethamine (47) 47
sarcoma, yoshida - therapy (44) 44
thymidine - metabolism (44) 44
drug resistance (43) 43
injections, intraperitoneal (42) 42
injections, intravenous (42) 42
sarcoma 180 - drug therapy (41) 41
cyclophosphamide - therapeutic use (40) 40
radionuclide imaging (39) 39
rats, wistar (39) 39
carbon isotopes (38) 38
drug synergism (36) 36
sarcoma, yoshida - physiopathology (36) 36
cancer (35) 35
carcinoma, hepatocellular - metabolism (35) 35
biochemistry & molecular biology (34) 34
electrophoresis (34) 34
autoradiography (33) 33
metabolism (33) 33
sarcoma, yoshida - radiotherapy (33) 33
carcinoma 256, walker (31) 31
carcinoma 256, walker - drug therapy (31) 31
lethal dose 50 (30) 30
body weight (29) 29
chromatography, gel (29) 29
cyclophosphamide - pharmacology (29) 29
methods (29) 29
neoplasms, experimental - pathology (29) 29
chromosomes (28) 28
dose-response relationship, drug (28) 28
microscopy, electron (28) 28
neoplasms - immunology (28) 28
sarcoma, experimental - drug therapy (28) 28
cricetinae (27) 27
dna, neoplasm - metabolism (27) 27
molecular weight (27) 27
sarcoma, yoshida - analysis (27) 27
antineoplastic agents - administration & dosage (26) 26
chemical phenomena (26) 26
fluorouracil - administration & dosage (26) 26
neoplasm proteins - biosynthesis (26) 26
alkylating agents - pharmacology (25) 25
carcinoma (25) 25
carcinoma 256, walker - metabolism (25) 25
chromatography (25) 25
histocytochemistry (25) 25
mitosis (25) 25
neoplasms - metabolism (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1253) 1253
German (250) 250
Japanese (246) 246
Italian (40) 40
Portuguese (18) 18
Russian (17) 17
French (9) 9
Spanish (8) 8
Chinese (7) 7
Czech (6) 6
Polish (3) 3
Hungarian (2) 2
Slovak (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nutrition and Cancer, ISSN 0163-5581, 07/2014, Volume 66, Issue 5, pp. 872 - 878
Journal Article
Journal Article
BBA - General Subjects, ISSN 0304-4165, 03/2013, Volume 1830, Issue 3, pp. 2770 - 2778
Cachexia is a wasting condition that manifests in several types of cancer, and the main characteristic is the profound loss of muscle mass. The Yoshida AH-130... 
Cancer cachexia | ANT1 | SERCA | Muscle wasting | Sarcoplasmic reticulum | Mitochondri | APOPTOSIS | TUMOR-BEARING RATS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-DEATH | HEAT-PRODUCTION | BIOPHYSICS | DNA FRAGMENTATION | CA2 | SKELETAL-MUSCLE FIBERS | ENDOPLASMIC-RETICULUM | DYSFUNCTION | VI MUSCULAR-DYSTROPHIES | Cachexia - complications | Adenosine Triphosphate - deficiency | Rats, Wistar | SKP Cullin F-Box Protein Ligases - genetics | Sarcoma, Yoshida - complications | Apoptosis - genetics | Male | Muscle, Skeletal - metabolism | Mitochondria - ultrastructure | Tripartite Motif Proteins | Cell Nucleus - metabolism | Proteolysis | Muscle Proteins - metabolism | Sarcoplasmic Reticulum - ultrastructure | Sarcoplasmic Reticulum - metabolism | Energy Metabolism - genetics | Muscular Atrophy - complications | Cachexia - metabolism | Adenine Nucleotide Translocator 1 - genetics | Gene Expression | Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism | Muscular Atrophy - metabolism | Muscular Atrophy - pathology | Ubiquitin-Protein Ligases - metabolism | Rats | Adenine Nucleotide Translocator 1 - metabolism | Mitochondria - metabolism | SKP Cullin F-Box Protein Ligases - metabolism | Cell Nucleus - ultrastructure | Muscle Proteins - genetics | Animals | Cachexia - pathology | Muscle, Skeletal - pathology | Sarcoma, Yoshida - pathology | Sarcoplasmic Reticulum Calcium-Transporting ATPases - genetics | Ubiquitin-Protein Ligases - genetics | Sarcoma, Yoshida - metabolism | Cachexia | Cancer
Journal Article
Journal Article
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 01/2010, Volume 99, Issue 1, pp. 549 - 562
Particles larger than a specific size have been thought to extravasate from tumor vessels but not from normal vessels. Therefore, various nanoparticles... 
drug targeting | macromolecular drug delivery | micelle | polymeric drug carrier | tumor vessels | EPR effect | permeability | cancer chemotherapy | cancer | vital microscopy | Macromolecular drug delivery | Vital microscopy | Cancer chemotherapy | Tumor vessels | Micelle | Drug targeting | Permeability | Polymeric drug carrier | Cancer | THERAPEUTICS | CHEMISTRY, MEDICINAL | PERMEABILITY FACTOR | CARRIER SYSTEM | RAT | TISSUE | ANTICANCER NANOMEDICINES | ANTITUMOR-ACTIVITY | BLOOD-FLOW | CHEMISTRY, MULTIDISCIPLINARY | PHARMACOLOGY & PHARMACY | ACCUMULATION | Biopolymers - chemistry | Capillary Permeability - physiology | Neoplasm Transplantation | Fluorescein-5-isothiocyanate - pharmacokinetics | Fluorescein-5-isothiocyanate - administration & dosage | Macromolecular Substances - administration & dosage | Rats | Male | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Rats, Inbred Strains | Neovascularization, Pathologic - pathology | Sarcoma, Yoshida - drug therapy | Animals | Microscopy, Fluorescence - methods | Micelles | Neovascularization, Pathologic - prevention & control | Sarcoma, Yoshida - blood supply | Aspartic Acid - chemistry | Sarcoma, Yoshida - pathology | Drug Delivery Systems - methods | Macromolecular Substances - therapeutic use
Journal Article
Cancer Gene Therapy, ISSN 0929-1903, 04/2003, Volume 10, Issue 4, pp. 318 - 329
Journal Article
Methods in molecular biology (Clifton, N.J.), 2019, Volume 1866, pp. 75 - 81
Methionine (MET) dependence is the elevated requirement of cancer cells for MET. Cancer cells are arrested when MET is restricted in late S/G phase of the cell... 
Human cancer | Nude mice | Sarcoma | Methionine dependence | Cell lines | Tumor growth inhibition | Methionine-free diet | Yoshida sarcoma
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2002, Volume 86, Issue 10, pp. 1604 - 1614
In a previous study, we used subcutaneous LY80 tumours (a subline of Yoshida sarcoma), Sato lung carcinoma, and methylcholanthrene-induced primary tumours, to... 
Microcirculation | Combretastatin A-4 | Tumour vessel | Metastasis | Tumour blood flow | Lung Neoplasms - drug therapy | Neoplasm Transplantation | Tumor Cells, Cultured - transplantation | Male | Lung Neoplasms - physiopathology | Heart Neoplasms - blood supply | Stomach Neoplasms - blood supply | Regional Blood Flow - drug effects | Antineoplastic Agents, Phytogenic - therapeutic use | Lung Neoplasms - blood supply | Carcinoma - drug therapy | Vasoconstrictor Agents - pharmacology | Vasoconstrictor Agents - therapeutic use | Serine - analogs & derivatives | Skin Window Technique | Rats | Liver Neoplasms, Experimental - blood supply | Lymphatic Metastasis | Sarcoma, Yoshida - physiopathology | Stomach Neoplasms - drug therapy | Organ Specificity | Carcinoma - physiopathology | Heart Neoplasms - drug therapy | Sarcoma, Yoshida - drug therapy | Animals | Liver Neoplasms, Experimental - drug therapy | Serine - pharmacology | Carcinoma - blood supply | Prodrugs - therapeutic use | Sarcoma, Yoshida - blood supply | Antineoplastic Agents, Phytogenic - pharmacology | Kidney Neoplasms - drug therapy | Prodrugs - pharmacology | Kidney Neoplasms - blood supply | Serine - therapeutic use | Drug Screening Assays, Antitumor | tumour vessel | tumour blood flow | combretastatin A-4 | metastasis | microcirculation | Experimental Therapeutics
Journal Article
Cancer, ISSN 0008-543X, 04/1992, Volume 69, Issue 7, pp. 1865 - 1872
Methionine‐depleting total parenteral nutrition (methionine‐depleting TPN), which infuses an amino acid solution devoid of L‐methionine and L‐cysteine as the... 
TUMOR | CELLS | ONCOLOGY | DEPRIVATION | CULTURE | TISSUE | Animals | Life Expectancy | Parenteral Nutrition, Total | Rats | Male | Sarcoma, Yoshida - therapy | Sarcoma, Yoshida - pathology | Rats, Inbred Strains | Cell Division - drug effects | Doxorubicin - pharmacology | Methionine - deficiency | Parenteral therapy | Care and treatment | Sarcoma | Growth | Methionine | Physiological aspects | Health aspects | Doxorubicin | Tumors
Journal Article